Insulin grew into a big business as the number of cases of diabetes ballooned across the globe. Diabetes was the first disease that was termed a lifestyle disease. Obesity is the reverse. It is often a problem amongst the poor who cannot afford high-quality foods and end up eating a lot of ultra-processed foods.

A drug is offering hope and billing itself as a solution to the problem. Its popularity has soared and caused the company that manufactures it to be valued more than the country in which it resides. This is the story of Wegovy and Novo Nordisk.

You can also read the entire article here

Source of assets used - Intro Music

You can also follow the podcast on Apple Podcast, Spotify, Amazon Music, Audible, and Podbean

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.learningbyproxy.com